The 2012 ASCO Annual Meeting

New research was presented at the 2012 American Society of Clinical Oncology annual meeting from June 1-5, 2012 in Chicago. The features below highlight just some of the studies that emerged from the conference. Examining Awareness of Late Effects of Cancer Treatment The Particulars: The population of cancer survivors continues to grow, but with it has come a growing number of patients who may experience the late or long-term effects (LEs) of treatment. Awareness on the part of oncologists and primary care providers (PCPs) of these LEs is not well understood. Data Breakdown: A nationally representative survey of oncologists and PCPs asked respondents to report the five LEs they had observed and/or seen reported in the literature for each of four standard chemotherapy agents for breast or colorectal cancer treatment. About one-third (65%) of oncologists identified the main LEs for all four chemotherapy drugs, but only 6% of PCPs accomplished the same feat. Oncologists were more likely to identify the main LEs if they spent 51% to 90% (odds ratio [OR], 1.87) or more than 90% (OR, 1.82) of their time on patient care. They were less likely to do so if they were not board certified. Take Home Pearls: Oncologists appear to often identify the main LEs of cancer treatment, while PCPs do not. Findings emphasize the importance of informing PCPs of the LEs of cancer treatments during patient transitions from oncology to primary care settings. Low-Dose Radiation Beneficial With CNS Lymphoma The Particulars: For many years, whole-brain radiation has been used to treat central nervous system (CNS) lymphoma, but this treatment has been associated with relatively poor...